When is standard treatment sufficiently active to make use of a placebo-controlled trial unethical?
- PMID: 20856725
- PMCID: PMC2790645
- DOI: 10.1200/JOP.0922503
When is standard treatment sufficiently active to make use of a placebo-controlled trial unethical?
Abstract
Research has demonstrated that double blinding can lessen the potential for bias in study outcomes, such as perceiving a drug as more effective in the experimental arm of a study. Effective double-blinding techniques minimize the influence of investigator and patient expectations.
Similar articles
-
Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture.BMC Med Res Methodol. 2018 Jan 18;18(1):13. doi: 10.1186/s12874-018-0474-1. BMC Med Res Methodol. 2018. PMID: 29347917 Free PMC article.
-
Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity.Clin Trials. 2010 Jun;7(3):246-55. doi: 10.1177/1740774510367916. Epub 2010 Apr 26. Clin Trials. 2010. PMID: 20421243 Review.
-
Behavioral research and the double-blind placebo-controlled methodology: challenges in applying the biomedical standard to behavioral headache research.Headache. 2005 May;45(5):479-86. doi: 10.1111/j.1526-4610.2005.05099.x. Headache. 2005. PMID: 15953264 Review.
-
Blinding strategies in the conduct and reporting of a randomized placebo-controlled device trial.Clin Trials. 2014 Oct;11(5):547-52. doi: 10.1177/1740774514535999. Epub 2014 Jun 5. Clin Trials. 2014. PMID: 24902921 Clinical Trial.
-
Blinding effectiveness and association of pretreatment expectations with pain improvement in a double-blind randomized controlled trial.Pain. 2002 Sep;99(1-2):91-9. doi: 10.1016/s0304-3959(02)00060-x. Pain. 2002. PMID: 12237187 Clinical Trial.
References
-
- Fossati R, Confalonieri C, Apolone G, et al: Does a drug do better when it is new? Ann Oncol 13:470-473, 2002 - PubMed
-
- Barbui C, Cipriani A, Brambilla P, et al: “Wish bias” in antidepressant drug trials? J Clin Psychopharmacol 24:126-130, 2004 - PubMed
-
- Daugherty CK, Ratain MJ, Emanuel EJ, et al: Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. J Clin Oncol 26:1371-1387, 2008 - PubMed
LinkOut - more resources
Full Text Sources